Compare · LFST vs OPCH
LFST vs OPCH
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.69B, about 1.3x OPCH ($3.54B).
- Over the past year, LFST is up 128.3% and OPCH is down 15.3% - LFST leads by 143.5 points.
- LFST has hit the wire 17 times in the past 4 weeks while OPCH has been quiet.
- Both have 17 recent analyst ratings on file.
- Company
- LifeStance Health Group Inc.
- Option Care Health Inc.
- Price
- -
- -
- Market cap
- $4.69B
- $3.54B
- 1M return
- +12.76%
- +8.46%
- 1Y return
- +128.25%
- -15.30%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 17
- 0
- Recent ratings
- 17
- 17
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFST
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Director Burdick Kenneth A sold $5,755,000 worth of shares (500,000 units at $11.51), decreasing direct ownership by 14% to 2,970,810 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Chief Technology Officer Paunovich Vukasin sold $481,675 worth of shares (44,394 units at $10.85), decreasing direct ownership by 15% to 247,446 units (SEC Form 4)
- Large owner Tpg Gp A, Llc sold $144,890,858 worth of shares (13,643,207 units at $10.62) (SEC Form 4)
- Chief Operating Officer Miller Lisa K sold $519,845 worth of shares (47,912 units at $10.85), decreasing direct ownership by 15% to 281,289 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.
Latest OPCH
- Option Care Health downgraded by Deutsche Bank with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations